Director, The Institute for Digital Medicine, National University of Singapore
Dean Ho is currently the Provost’s Chair professor; director of The Institute for Digital Medicine (WisDM); director of The N.1 Institute for Health; and Head of the Department of Biomedical Engineering at the National University of Singapore.
Ho is an internationally recognised leader in digital medicine. His team has pioneered the use of artificial intelligence towards life-saving outcomes in cancer, infectious diseases and beyond. Most recently, Ho led a team to address new areas of innovation, ranging from the design of novel treatments against Covid-19 to addressing food security.
Ho was also recently elected a Fellow of the American Association for the Advancement of Science – the only Singapore-based honouree in the 2021 Class. The lifetime honour is one of the most prestigious among innovators worldwide. His discoveries have been featured on CNN and CNA, and in The Economist, National Geographic, Forbes and other outlets. Ho is also a subgroup lead in the World Health Organization Working Group on regulating AI for healthcare applications.
Impacted Industries
Healthcare & Sciences
Awards
2018: Elected to the US National Academy of Inventors
2017: Fulbright Scholar, Core US Scholar Program, US Department of State
2016: Fellow, Society for Laboratory Automation and Screening
2015: William J Gies Award—International Association for Dental Research
2015: President, Board of Directors, Society for Laboratory Automation and Screening
2015: Top 10 Innovator—Journal of Laboratory Automation
2015: Fellow, American Institute for Medical and Biological Engineering
2014: Young Investigator Award—International Association for Dental Research
2014: Coulter Fellow, Wallace H Coulter Foundation
Did You Know?
Dr Dean Ho’s Curate.ai has been tested on liver-transplant and tuberculosis patients, with encouraging results.
